Idean M.

Idean M. has extensive work experience in finance and corporate affairs. In 2021, they became the CFO of Micron Biomedical, Inc., where they led the company to its first institutional financing (Series A) and raised $14MM to increase global access to therapeutics and vaccines with needless, simple, self-administration tech. From 2017 to 2021, Idean M. served as the Co-founder and head of finance & strategy of Antios Therapeutics, raising $201MM to develop a cure for hepatitis b. From 2012 to 2017, Idean M. was the Co-founder and head of finance & corporate affairs at G3 Therapeutics, raising $50MM to intersect human molecular profiles, AI, machine learning to develop diagnostics and therapeutics. Additionally, from 2012 to 2017, Idean M. was the Co-founder and head of finance & corporate affairs at Global Institute for Research, raising $2MM to build specialized boutique CRO. Idean M. began their career in 2010 as an Advisory at KPMG.

Idean M. attended the Georgia Institute of Technology and earned a Bachelor of Science in Management with High Honors.